ADVERTISEMENT
Wednesday, June 29th 2022
Today's Paper
The Kashmir Monitor
  • Login
₹ Contribute
No Result
View All Result
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
Today's Paper
The Kashmir Monitor
  • Login
Contribute
No Result
View All Result
The Kashmir Monitor
Home India

Hepatitis C drug Virafin gets DGCI nod for use in COVID cases

Monitor News Desk by Monitor News Desk
Apr. 24, 2021 Updated 4:26 pm. IST
A A
Zydus Virafin 23042021 1200
0
SHARES
95
VIEWS
Share on FacebookShare on Twitter


 

Amid a rather devastating surge in fresh Covid-19 cases in the country, the Drugs Controller General of India (DGCI) on Friday gave its approval to the emergency use of Virafin, a Hepatitis C drug manufactured by Zydus Cadila, to treat adult patients with moderate symptoms. 

ADVERTISEMENT

In an official statement, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said, “The fact that we are able to offer a therapy which significantly reduces the viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against Covid-19.”

What is Virafin?

In technical terms, Virafin is Pegylated Interferon alpha-2b, signaling proteins found in our bodies that act as immunological agents. This antiviral drug is administered via an injection.

Benefits of Virafin

The drug is shown to have helped COVID-19 patients, with mild symptoms, in recuperation. According to the claims of Zydus Cadila, Virafin will make COVID-19 treatment ‘less cumbersome and more affordable.

Why was Virafin given the DGCI nod?

During the Phase-III trial of the drug, 91.15% of the COVID-19 patients who participated in the test recovered from the virus in just seven days after being administered with the first dose, claimed Zydus Cadila.

ADVERTISEMENT

In fact, studies conducted in 2004 revealed that the drug is effective in the treatment of SARS, the first variant of coronavirus.

Where to buy Virafin?

As the drug has got the DGCI nod, it can now be sold at drug stores and other pharmacies. However, an individual will not be able to buy the drug over the counter. A doctor’s prescription will be needed for the same. The decision has been taken to prevent misuse of the drug.


Next Post
Oxygen in Kashmir: The complete story

Oxygen in Kashmir: The complete story

Discussion about this post

Logo

Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.

No Result
View All Result
  • Home Page
  • Latest News
  • Lead Stories
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Education
  • Business
  • Environment
  • Health
  • Sports
  • Editors’ Picks
  • Videos
  • Lifestyle
  • Tech-Film
  • Today’s Paper

Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In